Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users.

Jacobus J, Taylor CT, Gray KM, Meredith LR, Porter AM, Li I, Castro N, Squeglia LM.

Drug Alcohol Depend. 2018 Apr 11;187:195-204. doi: 10.1016/j.drugalcdep.2018.03.007. [Epub ahead of print]

PMID:
29679914
2.

From Content Knowledge to Community Change: A Review of Representations of Environmental Health Literacy.

Gray KM.

Int J Environ Res Public Health. 2018 Mar 7;15(3). pii: E466. doi: 10.3390/ijerph15030466. Review.

3.

Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection.

Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA.

Am J Drug Alcohol Abuse. 2018 Mar 7:1-16. doi: 10.1080/00952990.2018.1437445. [Epub ahead of print]

PMID:
29513609
4.

Caregiver Mental Health, Parenting Practices, and Perceptions of Child Attachment in Children with Autism Spectrum Disorder.

Teague SJ, Newman LK, Tonge BJ, Gray KM; MHYPeDD team.

J Autism Dev Disord. 2018 Mar 2. doi: 10.1007/s10803-018-3517-x. [Epub ahead of print]

PMID:
29500757
5.

The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.

Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM.

Drug Alcohol Depend. 2018 Apr 1;185:17-22. doi: 10.1016/j.drugalcdep.2017.12.005. Epub 2018 Feb 1.

PMID:
29413434
6.

THC potency needs to be tracked.

Gray KM.

Am J Addict. 2018 Jan;27(1):46. doi: 10.1111/ajad.12673. No abstract available.

PMID:
29283485
7.

Almond or Mahaleb? Orthogonal Allergen Analysis During a Live Incident Investigation by ELISA, Molecular Biology, and Protein Mass Spectrometry.

Walker MJ, Burns M, Quaglia M, Nixon G, Hopley CJ, Gray KM, Moore V, Singh M, Cowen S.

J AOAC Int. 2018 Jan 1;101(1):162-169. doi: 10.5740/jaoacint.17-0405. Epub 2017 Dec 5.

PMID:
29202918
8.

Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCFSlmb degron.

Gray KM, Kaifer KA, Baillat D, Wen Y, Bonacci TR, Ebert AD, Raimer AC, Spring AM, Have ST, Glascock JJ, Gupta K, Van Duyne GD, Emanuele MJ, Lamond AI, Wagner EJ, Lorson CL, Matera AG.

Mol Biol Cell. 2018 Jan 15;29(2):96-110. doi: 10.1091/mbc.E17-11-0627. Epub 2017 Nov 22.

PMID:
29167380
9.

Parenting and family adjustment scales (PAFAS): validation of a brief parent-report measure for use with families who have a child with a developmental disability.

Mazzucchelli TG, Hodges J, Kane RT, Sofronoff K, Sanders MR, Einfeld S, Tonge B, Gray KM; MHYPEDD Project Team.

Res Dev Disabil. 2018 Jan;72:140-151. doi: 10.1016/j.ridd.2017.10.011. Epub 2017 Nov 14.

PMID:
29145013
10.

Troponin Limit of Detection Plus Cardiac Risk Stratification Scores to Rule Out Acute Myocardial Infarction and 30-Day Major Adverse Cardiac Events in ED Patients.

Datlow MD, Gray KM, Watts A, Diercks DB, Mumma BE.

Crit Pathw Cardiol. 2017 Dec;16(4):142-146. doi: 10.1097/HPC.0000000000000129.

PMID:
29135622
11.

A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects.

Carpenter MJ, Heckman BW, Wahlquist AE, Wagener TL, Goniewicz ML, Gray KM, Froeliger B, Cummings KM.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1795-1803. doi: 10.1158/1055-9965.EPI-17-0460. Epub 2017 Nov 10.

PMID:
29127080
12.

Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.

Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM.

Drug Alcohol Depend. 2018 Jan 1;182:1-7. doi: 10.1016/j.drugalcdep.2017.09.035. Epub 2017 Nov 2.

PMID:
29112827
13.

Country of Birth of Children With Diagnosed HIV Infection in the United States, 2008-2014.

Nesheim SR, Linley L, Gray KM, Zhang T, Shi J, Lampe MA, FitzHarris LF.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):23-30. doi: 10.1097/QAI.0000000000001572.

PMID:
29040167
14.

Concurrence of the strengths and difficulties questionnaire and developmental behaviour checklist among children with an intellectual disability.

Rice LJ, Emerson E, Gray KM, Howlin P, Tonge BJ, Warner GL, Einfeld SL.

J Intellect Disabil Res. 2018 Feb;62(2):150-155. doi: 10.1111/jir.12426. Epub 2017 Oct 5.

PMID:
28980362
15.

Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles.

Patel DB, Gray KM, Santharam Y, Lamichhane TN, Stroka KM, Jay SM.

Bioeng Transl Med. 2017 Jun 26;2(2):170-179. doi: 10.1002/btm2.10065. eCollection 2017 Jun.

16.

Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.

Hser YI, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou CP, Gray KM.

J Subst Abuse Treat. 2017 Oct;81:53-58. doi: 10.1016/j.jsat.2017.07.012. Epub 2017 Jul 29.

PMID:
28847455
17.

Research Review: What have we learned about adolescent substance use?

Gray KM, Squeglia LM.

J Child Psychol Psychiatry. 2017 Jul 17. doi: 10.1111/jcpp.12783. [Epub ahead of print] Review.

PMID:
28714184
18.

Systematic Review and Meta-analysis of Parent Group Interventions for Primary School Children Aged 4-12 Years with Externalizing and/or Internalizing Problems.

Buchanan-Pascall S, Gray KM, Gordon M, Melvin GA.

Child Psychiatry Hum Dev. 2018 Apr;49(2):244-267. doi: 10.1007/s10578-017-0745-9.

PMID:
28699101
19.

Vascular endothelial cell mechanosensing: New insights gained from biomimetic microfluidic models.

Gray KM, Stroka KM.

Semin Cell Dev Biol. 2017 Nov;71:106-117. doi: 10.1016/j.semcdb.2017.06.002. Epub 2017 Jun 17. Review.

PMID:
28633977
20.

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR.

Drug Alcohol Depend. 2017 Aug 1;177:249-257. doi: 10.1016/j.drugalcdep.2017.04.020. Epub 2017 Jun 10.

PMID:
28623823
21.

Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.

McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM.

Drug Alcohol Depend. 2017 Jul 1;176:14-20. doi: 10.1016/j.drugalcdep.2017.02.024. Epub 2017 May 10.

22.

Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability.

Froeliger B, McConnell PA, Bell S, Sweitzer M, Kozink RV, Eichberg C, Hallyburton M, Kaiser N, Gray KM, McClernon FJ.

JAMA Psychiatry. 2017 Apr 1;74(4):379-386. doi: 10.1001/jamapsychiatry.2017.0017.

23.

Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.

Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM.

Am J Addict. 2017 Mar;26(2):136-144. doi: 10.1111/ajad.12503. Epub 2017 Feb 2.

24.

Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review.

Adisetiyo V, Gray KM.

Am J Addict. 2017 Mar;26(2):99-111. doi: 10.1111/ajad.12500. Epub 2017 Jan 20. Review.

PMID:
28106934
25.

Pharmacotherapy for Substance Use Disorders in Youths.

Hammond CJ, Gray KM.

J Child Adolesc Subst Abuse. 2016;25(4):292-316. doi: 10.1080/1067828X.2015.1037517. Epub 2016 Apr 20.

26.

Perceptions of Snus Among US Adult Smokers Given Free Product.

Meier E, Burris JL, Wahlquist A, Garrett-Mayer E, Gray KM, Alberg AJ, Cummings KM, Carpenter MJ.

Nicotine Tob Res. 2017 Dec 13;20(1):22-29. doi: 10.1093/ntr/ntw392.

PMID:
28034999
27.

Factors affecting implementation of perinatal mental health screening in women of refugee background.

Nithianandan N, Gibson-Helm M, McBride J, Binny A, Gray KM, East C, Boyle JA.

Implement Sci. 2016 Nov 18;11(1):150.

28.

Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers.

Tomko RL, Saladin ME, McClure EA, Squeglia LM, Carpenter MJ, Tiffany ST, Baker NL, Gray KM.

Psychopharmacology (Berl). 2017 Feb;234(3):427-435. doi: 10.1007/s00213-016-4472-x. Epub 2016 Nov 12.

29.

Mobile devices for the remote acquisition of physiological and behavioral biomarkers in psychiatric clinical research.

W Adams Z, McClure EA, Gray KM, Danielson CK, Treiber FA, Ruggiero KJ.

J Psychiatr Res. 2017 Feb;85:1-14. doi: 10.1016/j.jpsychires.2016.10.019. Epub 2016 Oct 22. Review.

30.

A qualitative study of attachment relationships in ASD during middle childhood.

Keenan BM, Newman LK, Gray KM, Rinehart NJ.

Attach Hum Dev. 2017 Feb;19(1):1-21. Epub 2016 Oct 28.

PMID:
27788627
31.

SMN - A chaperone for nuclear RNP social occasions?

Raimer AC, Gray KM, Matera AG.

RNA Biol. 2017 Jun 3;14(6):701-711. doi: 10.1080/15476286.2016.1236168. Epub 2016 Sep 20. Review.

32.

A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.

Back SE, McCauley JL, Korte KJ, Gros DF, Leavitt V, Gray KM, Hamner MB, DeSantis SM, Malcolm R, Brady KT, Kalivas PW.

J Clin Psychiatry. 2016 Nov;77(11):e1439-e1446. doi: 10.4088/JCP.15m10239.

33.

Computerised attention training for children with intellectual and developmental disabilities: a randomised controlled trial.

Kirk HE, Gray KM, Ellis K, Taffe J, Cornish KM.

J Child Psychol Psychiatry. 2016 Dec;57(12):1380-1389. doi: 10.1111/jcpp.12615. Epub 2016 Aug 23.

PMID:
27550746
34.

Collaborating for Systems Change: A Social Science Framework for Academic Roles in Community Partnerships.

Korfmacher KS, Pettibone KG, Gray KM, Newman OD.

New Solut. 2016 Aug 17. pii: 1048291116662680. [Epub ahead of print]

35.

Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.

Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM.

Addict Behav. 2016 Dec;63:172-7. doi: 10.1016/j.addbeh.2016.08.001. Epub 2016 Aug 4.

36.

Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review.

Tomko RL, Bountress KE, Gray KM.

Drug Alcohol Depend. 2016 Oct 1;167:1-7. doi: 10.1016/j.drugalcdep.2016.07.022. Epub 2016 Jul 27. Review.

37.

A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus.

Burris JL, Wahlquist AE, Alberg AJ, Cummings KM, Gray KM, Garrett-Mayer E, Carpenter MJ.

Addict Behav. 2016 Dec;63:82-8. doi: 10.1016/j.addbeh.2016.07.008. Epub 2016 Jul 15.

38.

HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013.

Karch DL, Gray KM, Shi J, Hall HI.

Open AIDS J. 2016 Jun 15;10:127-35. doi: 10.2174/1874613601610010127. eCollection 2016.

39.

A cross-syndrome evaluation of a new attention rating scale: The Scale of Attention in Intellectual Disability.

Freeman NC, Gray KM, Taffe JR, Cornish KM.

Res Dev Disabil. 2016 Oct;57:18-28. doi: 10.1016/j.ridd.2016.06.005. Epub 2016 Jun 24.

PMID:
27348856
40.

A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder.

Dean OM, Gray KM, Villagonzalo KA, Dodd S, Mohebbi M, Vick T, Tonge BJ, Berk M.

Aust N Z J Psychiatry. 2017 Mar;51(3):241-249. doi: 10.1177/0004867416652735. Epub 2016 Jul 11.

PMID:
27316706
41.

Parents of Children with ASD Experience More Psychological Distress, Parenting Stress, and Attachment-Related Anxiety.

Keenan BM, Newman LK, Gray KM, Rinehart NJ.

J Autism Dev Disord. 2016 Sep;46(9):2979-91. doi: 10.1007/s10803-016-2836-z.

PMID:
27312716
42.

Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood.

Foster KT, Li N, McClure EA, Sonne SC, Gray KM.

J Subst Abuse Treat. 2016 Jul;66:16-22. doi: 10.1016/j.jsat.2016.01.012. Epub 2016 Feb 13.

43.

Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers.

Carpenter MJ, Wahlquist AE, Burris JL, Gray KM, Garrett-Mayer E, Cummings KM, Alberg AJ.

Tob Control. 2017 Mar;26(2):202-209. doi: 10.1136/tobaccocontrol-2015-052783. Epub 2016 Apr 12.

44.

Alcohol and Drug Use and the Developing Brain.

Squeglia LM, Gray KM.

Curr Psychiatry Rep. 2016 May;18(5):46. doi: 10.1007/s11920-016-0689-y. Review.

45.

Autism Spectrum Disorder in the DSM-5: Diagnostic Sensitivity and Specificity in Early Childhood.

Christiansz JA, Gray KM, Taffe J, Tonge BJ.

J Autism Dev Disord. 2016 Jun;46(6):2054-2063. doi: 10.1007/s10803-016-2734-4.

PMID:
26861716
46.

The Developmental Trajectory of Self-Injurious Behaviours in Individuals with Prader Willi Syndrome, Autism Spectrum Disorder and Intellectual Disability.

Rice LJ, Gray KM, Howlin P, Taffe J, Tonge BJ, Einfeld SL.

Diseases. 2016 Feb 6;4(1). pii: E9. doi: 10.3390/diseases4010009.

47.

Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.

Bentzley JP, Tomko RL, Gray KM.

J Subst Abuse Treat. 2016 Apr;63:72-7. doi: 10.1016/j.jsat.2015.12.003. Epub 2015 Dec 28.

48.

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.

Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, Gray KM, McRae-Clark A, Lofwall MR, Sparenborg S, Walsh SL.

Neuropsychopharmacology. 2016 Jul;41(8):1974-82. doi: 10.1038/npp.2015.367. Epub 2015 Dec 28.

49.

Vilazodone for cannabis dependence: A randomized, controlled pilot trial.

McRae-Clark AL, Baker NL, Gray KM, Killeen T, Hartwell KJ, Simonian SJ.

Am J Addict. 2016 Jan;25(1):69-75. doi: 10.1111/ajad.12324. Epub 2015 Dec 20.

50.

Determining menstrual phase in human biobehavioral research: A review with recommendations.

Allen AM, McRae-Clark AL, Carlson S, Saladin ME, Gray KM, Wetherington CL, McKee SA, Allen SS.

Exp Clin Psychopharmacol. 2016 Feb;24(1):1-11. doi: 10.1037/pha0000057. Review.

Supplemental Content

Support Center